Welcome to LookChem.com Sign In|Join Free
  • or
α-[(Diethoxyphosphinyl)methyl]benzenepropanoic acid is a complex organic compound with the chemical formula C13H21O5P. It is a derivative of benzenepropanoic acid, featuring a diethoxyphosphinyl group attached to the α-carbon. This molecule is characterized by its ability to form esters and has potential applications in the synthesis of various pharmaceuticals and agrochemicals due to its unique structure. The presence of the phosphorus atom and the ester functionality make it a compound of interest in the field of organophosphorus chemistry.

95272-47-2

Post Buying Request

95272-47-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

95272-47-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 95272-47-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,2,7 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 95272-47:
(7*9)+(6*5)+(5*2)+(4*7)+(3*2)+(2*4)+(1*7)=152
152 % 10 = 2
So 95272-47-2 is a valid CAS Registry Number.

95272-47-2Downstream Products

95272-47-2Relevant academic research and scientific papers

Synthesis and biological activity of some transition-state inhibitors of human renin

Buhlmayer,Caselli,Fuhrer,Goschke,Rasetti,Rueger,Stanton,Criscione,Wood

, p. 1839 - 1846 (2007/10/02)

A series of renin inhibitors containing the dipeptide transition state mimics (2S,4S,5S)-5-amino-4-hydroxy-2-isopropyl-7-methyloctanoic acid (Leu-(OH)-Val) and (2S,4S,5S)-5-amino-4-hydroxy-2-isopropyl-6-cyclohexylhexanoic acid (Cha-(OH)-Val) was prepared.

NOVEL 5-AMINO-4-HYDROXYVALERYL DERIVATIVES

-

, (2008/06/13)

Compounds of the formula STR1 in which R 1 represents hydrogen or acyl, A represents an optionally N-alkylated α-amino acid residue which is bonded N-terminally to R 1 and C-terminally to the group--NR 2--, R 2 represents hydrogen or lower alkyl, R 3 represents hydrogen, lower alkyl, optionally etherified or esterified hydroxy-lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, bicycloalkyl-lower alkyl, tricycloalkyl-lower alkyl, aryl or aryl-lower alkyl, R 4 represents hydroxy or etherified or esterified hydroxy, R 5 represents lower alkyl having 2 or more carbon atoms, optionally etherified or esterified hydroxy-lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, bicycloalkyl, bicycloalkyl-lower alkyl, tricycloalkyl, tricycloalkyl-lower alkyl, aryl, aryl-lower alkyl, optionally substituted carbamoyl, optionally substituted amino, optionally substituted hydroxy or optionally substituted mercapto and R 6 represents substituted amino, and salts of such compounds having salt-forming groups inhibit the blood pressure-increasing action of the enzyme renin and can be used as antihypertensives.

Pharmaceutical amides, and preparation, formulations and use of thereof

-

, (2008/06/13)

Compounds of the general formula STR1 wherein Ph is a phenyl group which is optionally substituted by one or more substituents selected from halo (i.e. fluoro, chloro, bromo or iodo), C1-4 alkyl, amino, C1-4 alkylamino, di-C1-4 alkylamino, nitro, sulphonyl, aminosulphonyl, trihalomethyl, carboxy, C1-4 alkoxycarbonyl, amido, C1-4 alkylamido C1-4 alkoxy, C2-4 alkenyl, cyano, aminomethyl or methylsulphonyl; Ra and Rb, which may be the same or different, each represents a hydrogen or alkali metal (e.g. sodium or lithium) atom or a C1-4 (e.g. ethyl) group; m is 0 or 1; Y is a group of formula: or a group of formula: STR2 where R1 is hydrogen or methyl; R2 is alkyl of 1 to 3 carbon atoms or is methylthiomethyl; and Z is --OR3 or --NR4 R5 where R3, R4 and R5 are each hydrogen or alkyl of 1 to 4 carbon atoms (i.e. methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or t-butyl) and R3 can further be phenylalkyl having 1 to 3 carbon atoms in the alkylene moiety thereof, or phenyl; and basic salts thereof. These compounds have an advantageous enkephalinase inhibitory activity which renders the compounds useful in medical therapy, e.g. to prolong and/or potentiate in a mammal, the effects of endogenous or exogenous enkephalins. The latter includes synthetic enkepalin analogues.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 95272-47-2